Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7)

Pancreatology

Volumn 12, Issue 5, 2012, Pages 451-457

  Wang, Yan ^a   Wang, Jing ^a   Liu, Ruixia ^a   Qi, Haiyu ^a   Wen, Yan ^a   Sun, Fangfang ^a   Yin, Chenghong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

ACE; ACE2; Angiotensin (1 7) Mas receptor; Angiotensin II; Severe acute pancreatitis

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; CERULETIDE; MAS RECEPTOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84873096433     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2012.07.017     Document Type: Article

References (43)

1. Rosenberg ME, Smith LJ, Correa-Rotter R, Hostetter TH The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 1994; 45: 403-10. (Pubitemid 24065073)
2. Pagliaro P, Penna C. Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 2005; 19: 77-87. (Pubitemid 40767775)
3. Ferrario CM, Trask AJ, Jessup JA Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005; 289: H2281-90. (Pubitemid 41698533)
4. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994; 23: 258-68.
5. Osterreicher CH, Taura K, De Minicis S, Seki E, Penz-Osterreicher M, Kodama Y. Angiotensin e converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 2009; 50: 929-38.
6. Cooper ME, Tikellis C, Thomas MC Preventing diabetes in patients with hypertension: one more reason to block the reninangiotensin system. J Hypertens Suppl 2006; 24: S57-63. (Pubitemid 44336825)
7. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol 2007; 1: 31-7. (Pubitemid 46470642)
8. Tsang SW, Ip SP, Leung PS Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol 2004; 36: 330-9. (Pubitemid 37487767)
9. Lai PB. Local renin-angiotensin system in the pancreas: the significance in acute pancreatitis. JOP 2001; 2: 13-5. (Pubitemid 38963879)
10. Oruc N, Ozutemiz O, Nart D., Yuce G, Celik HA, Ilter T. Inhibition of reninangiotensin system in experimental acute pancreatitis in rats: a new therapeutic target. Exp Toxicol Pathol 2010; 62: 353-60.
11. Leung PS, Chan WP, Nobiling R. Regulated expression of pancreatic reninangiotensin system in experimental pancreatitis. Mol Cell Endocrinol 2000; 166: 121-8.
12. Tsang SW, Cheng CH, Leung PS The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept 2004; 119: 213-9. (Pubitemid 38553840)
13. Greenstein RJ, Krako LR, Felton K. Activation of the renin system in acute pancreatitis. Am J Med 1987; 82: 401-4.
14. Kuwahira I, Gonzalez NC, Heisler N, Piiper J. Changes in regional blood-flow distribution and oxygen-supply during hypoxia in conscious rats. J Appl Physiol 1993; 74: 211-4. (Pubitemid 23059747)
15. Knoefel WT, Kollias N, Warshaw A.L., Waldner H., Nishioka NS, Rattner DW Pancreatic microcirculatory changes in experimental pancreatitis of graded severeity in rat. Surgery 1994; 116: 904-13. (Pubitemid 24347201)
16. Ibiş M, Yüksel O, Yilmaz G, Köklü S, Yilmaz FM, Ertugrul I, et al. Serum angiotensin converting enzyme levels in pancreatic diseases. Hepatogas- troenterology 2008; 55: 1814-7.
17. Ulmasov B, Xu Z, Talkad V., Oshima K, Neuschwander-Tetri BA. Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol 2010; 299: G70-80.
18. Donoghue M, Hsieh F, Baronas E., Godbout K, Gosselin M, Stagliano N., et al A novel angiotensin-converting enzyme-related carboxy peptidase(ACE2) converts angiotensin | to angiotensin-(1-9). Circ Res 2000; 87: E1-9.
19. Tipnis SR, Hooper NM, Hyde R, Karran E., Christie G, Turner AJ A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxpeptidase. J Bid Chen 2000; 275: 33238-43.
20. Vickers C, Hales P, Kaushik V., Dick L, Gavin J, Tang J., et al Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277: 14838-43. (Pubitemid 34952556)
21. Brosnihan KB, Li P, Ferrario CM Angiotensin-(1-7) dilates canine coronary arteries through kinin and nitric oxide. Hypertension 1996; 27: 523-8. (Pubitemid 26086221)
22. Sampaio WO, Souza dos Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007; 49: 185-92. (Pubitemid 46360359)
23. Niu MJ, Yang JK, Lin S.S., Ji XJ, Guo LM Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice. Endocrine 2008; 34: 56-61.
24. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol 2009; 302: 193-202.
25. Bindom SM, Hans CP, Xia H, Boulares A.H., Lazartigues E. Angiotensin-con-verting enzyme type 2 (ACE2) gene therapy improves glycemic normal in diabetic mice. Diabetes 2010; 59: 2540-8.
26. Weylandt KH, Nadolny A, Kahlke L., Kohnke T, Schmocker C, Wang J., et al Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis. Biochim Biophys Acta 2008; 1782: 634-41.
27. Ghiani BU, Masini MA Angiotensin II binding sites in the rat pancreas and their modulation after sodium loading and depletion. Comp Biochem Physiol A Physiol 1995; 111: 439-44.
28. Tahmasebi M, Puddefoot JR, Inwang E.R., Vinson GP The tissue reninangiotensin system in human pancreas. J Endocrinol 1999; 161: 317-22. (Pubitemid 29244259)
29. 1 expression in the pancreas of diabetic rat. Exp Clin Endocrinol Diabetes 2009; 117: 438-9.
30. Leung PS, Chappell MC A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol 2003; 35: 838-46. (Pubitemid 36379325)
31. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin e angiotensin system. Regul Pept 1993; 43: 1-20.
32. Morrell NW, Atochina EN, Morris K.G., Danilov SM, Stenmark KR Angiotensin converting enzyme is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest 1995; 96: 1823-33.
33. Chan WP, Fung ML, Leung PS Activation of local renin-angiotensin system by chronic hypoxia. Mol Cell Endocrinol 2000; 160: 107-14.
34. Oldner A, Wanecek M, Weitzberg E., Rundgren M, Alving K, Ullman J., et al Angiotensin | receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 1999; 11: 127-35.
35. Ulmasov B, Xu Z, Tetri L.H., Inagami T., Neuschwander-Tetri BA. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol 2009; 296: G284-94.
36. Giani JF, Mayer MA, Muñoz MC, Silberman E.A., Höcht C, Taira C.A., et al Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009; 296: E262-71.
37. Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007; 50: 1093-8. (Pubitemid 350172931)
38. Jackman HL, Massad MG, Sekosan M, Tan F., Brovkovych V, Marcic BM, et al Angiotensin-(1-9) and angiotensin-(1-7) release in human heart role of cathepsin A. Hypertension 2002; 39: 976-81. (Pubitemid 34547796)
39. Zeng W, Chen W, Leng X., He JG, Ma H. Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits. Biochem Biophys Res Commun 2009; 389: 138-44.
40. Gomes ER, Lara AA, Almeida P.W., Guimarães D, Resende R.R., Campagnole-Santos MJ, et al Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway. Hypertension 2010; 55(1): 153-60.
41. Su Z, Zimpelmann J, Burns KD Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69: 2212-8. (Pubitemid 43882108)
42. Lara LS, De Carvalho T, Leao-Ferreira LR, Lopes A.G., Caruso-Neves C. Modulation of the (Na(+) + K+) ATPase activity by Angiotensin-(1-7) in MDCK cells. Regul Peptides 2005; 129: 221-6. (Pubitemid 40775806)
43. da Silveira K.D., Coelho FM, Vieira A.T., Sachs D., Barroso LC, Costa VV, et al Antiinflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis. J Immunol 2010; 185: 5569-76.